Live tape
Top 8, mentions 7d10,776GOOGL2,063 mentions▲ +0.04SNDK1,523 mentions▲ +0.11SPCX1,494 mentions▲ +0.08NBIS1,420 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,189 mentions▲ +0.08META1,016 mentions▲ +0.03MSFT839 mentions▲ +0.06

Equity · Healthcare

SNSE

Sensei Biotherapeutics Inc · NGM

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for SNSE to draw a line in its place.

The chart above plots the price of SNSE over the range selected — one day to the full history — drawn by TradingView from their own data.

SNSE insider trades

SEC Form 4 · last 90 days · newest reported trade 1 Jun 2026
Open-market buys 0
Open-market sells 2
Net sold $1.00M
Non-trade filings 0
Date Insider Type Shares Value
01 Jun 2026 Cambrian BioPharma Inc 10% Owner Sell 25,000 $501K
01 Jun 2026 Peyer James 10% Owner Sell 25,000 $501K

SNSE earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-131.45
31 Dec 2025 FY 2025 $-16.72
30 Sep 2025 Q3 2025 $-3.62
30 Jun 2025 Q2 2025 $-3.91
31 Mar 2025 Q1 2025 $-5.45
31 Dec 2024 FY 2024 $-24.01
30 Sep 2024 Q3 2024 $-5.77
30 Jun 2024 Q2 2024 $-5.69

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

SNSE institutional holders

SEC Form 13F

5 of the 45 institutional funds we track reported a SNSE position for the quarter ended 30 Jun 2026 — a combined $64.2M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Baker Bros. Advisors New position 1,286,411 $32.2M
Balyasny Asset Management Added +6,331.3% shares 1,042,198 $26.1M
Marshall Wace Added +214.2% shares 206,508 $5.2M
Renaissance Technologies Trimmed −36.3% shares 20,416 $510K
Citadel Advisors New position 12,296 $307K

Source: SEC EDGAR 13F filings